Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse/Monkey |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Interleukin-7 receptor subunit alpha (410-459 aa) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000ELISA 1:40000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
IL7R |
Gene ID: |
3575 |
Uniprot ID: |
IL7RA_HUMAN |
Immunogen Region: |
410-459 aa |
Specificity: |
IL-7R Polyclonal Antibody detects endogenous levels of IL-7R protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human IL-7R/CD127 at the amino acid range 410-459 |
Function | Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP). |
Protein Name | Interleukin-7 Receptor Subunit AlphaIl-7 Receptor Subunit AlphaIl-7r Subunit AlphaIl-7r-AlphaIl-7raCdw127Cd Antigen Cd127 |
Database Links | Reactome: R-HSA-1266695Reactome: R-HSA-8856825Reactome: R-HSA-8856828 |
Cellular Localisation | Isoform 1: Cell MembraneSingle-Pass Type I Membrane ProteinIsoform 3: Cell MembraneIsoform 4: Secreted |
Alternative Antibody Names | Anti-Interleukin-7 Receptor Subunit Alpha antibodyAnti-Il-7 Receptor Subunit Alpha antibodyAnti-Il-7r Subunit Alpha antibodyAnti-Il-7r-Alpha antibodyAnti-Il-7ra antibodyAnti-Cdw127 antibodyAnti-Cd Antigen Cd127 antibodyAnti-IL7R antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance